💨 Abstract

Kura Oncology Inc. reported a loss of $66.1 million in Q2 2025, which was worse than analysts' expectations. The company's earnings per share were -$0.75 versus the expected $0.15, and revenue was $15.3 million, significantly below the forecasted $141.9 million.

Courtesy: WTOP Staff